NEO PROMETHEUS PROTOCOL

LONGEVITYSCIENCE STARTS WITH CELLULAR INSIGHT

SCROLL TO EXPAND

Our MissionPioneering responsible longevity science through research, education, and AI-assisted insight

NovaGen Group is building a research-led platform across cellular science, AI health intelligence, and partner-network education.

We focus on educational information, investigational research context, and tools that support qualified clinical discussion.

Learn More

Certified Excellence

Controlled laboratory context
XPRIZE Logo
Healthspan Semi-Finalist
UCLA Logo
Research Partnership
Nature Journal Logo
+others 190+ Publications
Controlled laboratory context
XPRIZE Logo
Healthspan Semi-Finalist
UCLA Logo
Research Partnership
Nature Journal Logo
+others 190+ Publications

The Neo Prometheus ProtocolIn Action

Our investigational research program combines cellular science, structured laboratory workflows, and partner-network education.

Cellular Research

Explore how cellular aging markers are studied through the investigational Neo Prometheus Protocol.

Biomarker Review

Review cellular and molecular markers as educational inputs for qualified clinical discussion.

Structured Workflow

From information request to partner-clinic review, the workflow is designed for structured evaluation.

Research Areas

Educational research across cellular health, tissue biology, immune signaling, metabolism, and healthspan science.

The Journey to Renewal

The Rejuvenation Process

From collection to results in six precise steps.

1

Clinical Partner Review

A licensed provider reviews whether any sample collection is appropriate and permitted

2

Sample Handling

Cellular material may be isolated and expanded through controlled laboratory workflows

3

Research Workflow

The investigational protocol studies changes in cellular aging markers

4

Quality Validation

Analytical review may include molecular and cellular marker assessment

5

Provider-Led Decision

Any clinical use is determined by independent licensed providers under applicable rules

6

Follow-Up Review

Follow-up information is reviewed as observational data and educational context

Learn how the investigational workflow is structured for review by qualified clinical partners.

Learn More

The Science Behind the Neo Prometheus Protocol

Why Epigenetic Reprogramming Works

Aging isn't about worn-out parts—it's about cells that have forgotten how to function. Neo Prometheus Protocol doesn't replace your cells; it updates their operating system.

Based on Dr. Sun's 190+ publications (20,000+ citations) in Nature, Science, and Cell.

Senolytics

Senescent cells accumulate with age and are one area of active longevity research. NovaGen Group studies how cellular programs may be characterized and monitored.

Epigenetics

DNA methylation patterns are one way researchers study cellular aging. Neo Prometheus Protocol explores epigenetic reprogramming concepts without DNA editing.

Metabolism

Mitochondrial function changes with age. Research workflows monitor energy-related markers alongside other cellular signals.

Immunology

Immune signaling is part of the broader cellular aging landscape and remains an important area for preclinical and translational research.

Global Elite Partner Network

Partner Network

NovaGen Group works with selected partner environments for educational access, clinical discussion, and research-context review where permitted.

Clinique DelMar Antibes

Antibes, France

Clinique DelMar

A partner setting on the Côte d'Azur for clinical discussion and research-context access led by qualified providers where permitted.

Partner Location
FLCHUAE

Planned Partnerships

Global Expansion

NovaGen Group is evaluating additional partner relationships in selected jurisdictions. Availability depends on local governance and provider review.

The Neo Prometheus Protocol

Considerations (Educational Only)

This overview is for adults discussing investigational longevity research with qualified physicians.

The following information is educational only and does not determine medical suitability.

Criteria & Screening

Topics to Discuss With a Physician

These examples are educational prompts only. Suitability, if any, must be determined by independent licensed providers.

Global clinic network and patient presence

Criteria & Screening:

18+

Adult-focused information

Review

Physician-led assessment required

Required

Availability varies by jurisdiction

Protocol Considerations:

Adults interested in longevity science and cellular health education

People preparing questions for an independent physician review

Individuals exploring preventive health and healthspan education

Research participants where local rules and provider oversight allow

Those interested in biomarker literacy and longitudinal data review

High-demand professionals seeking structured wellness information

Participation and clinical access are jurisdiction-dependent and require independent provider review.

Request Information

Request educational resources to support a discussion with your healthcare provider.

Our Team

World-Class Leadership

Led by experienced executives and guided by distinguished advisors

Leadership Team

Operators, scientists, and builders coordinating NovaGen Group's research-led platform.

8 leaders

Diederik van der Reijt, CEO

Diederik van der Reijt

CEO

Diederik van der Reijt is the CEO and Co-founder. A serial biotech entrepreneur and investor, he previously built a successful high-frequency trading firm and co-founded NKore Biotherapeutics, and now leverages his finance and venture capital background to democratize access to breakthrough cellular therapies.

Dr. Yi Eve Sun, Chief Scientific Officer

Dr. Yi Eve Sun

Chief Scientific Officer

Professor, UCLA Department of Molecular & Medical Pharmacology. Pioneer in neural stem cell biology and leading expert in cellular reprogramming. Academic excellence with breakthrough discoveries in JAK-STAT pathways and successful translation from bench to bedside.

Dr. Henk Viëtor, Chief Medical Officer

Dr. Henk Viëtor

Chief Medical Officer

Co-founded and led more than 20 life sciences companies, including Drug Discovery Factory, Skyline Diagnostics, Julius Clinical, DC4U, MyLife Technologies, and Oncodrone. Physician, scientist, and serial biotech entrepreneur with expertise in clinical immunology, transfusion medicine, and genetics.

Karen Brink, Chief Growth Officer

Karen Brink

Chief Growth Officer

Karen Brink leads growth strategy and thought leadership for the company’s cellular longevity platform. An experienced healthcare investor and company founder, she has launched several healthcare ventures and holds a Blockchain Strategy degree from Oxford.

Jimmy Zhu Wenmin, Chief Development Officer

Jimmy Zhu Wenmin

Chief Development Officer

Seasoned business professional with a strong track record in commercializing innovative healthcare technologies in China. Proven leader in scaling ventures, securing strategic partnerships, and driving global market expansion.

Dr. Digvijay Gahtory, Chief Business Officer

Dr. Digvijay Gahtory

Chief Business Officer

Has over 8 years of experience in strategy consulting and entrepreneurship. Has raised more than €100 million in financing for life science companies. Founder and CEO of Bimini Biotech.

Rhys Tombling, Finance Director

Rhys Tombling

Finance Director

Has 10 years of experience in the private sector, specializing in financial control & operations for start-ups and scale-ups in FMCG and SaaS. Holds an ACA-ICAEW accountancy qualification and a BA in Accountancy and Finance from Newcastle University.

Daniel Erasmus, Chief AI Architect

Daniel Erasmus

Chief AI Architect

He is a member of the OECD's AI Expert Group and CEO of Erasmus.AI, a platform creating domain-specific AI models like ClimateGPT, the world's first foundational Climate Change model. With 25 years of experience in strategy and foresight advisory, he is also a full member of the Club of Rome.

Medical & Scientific Board

Scientific and clinical advisors supporting research context and review.

6 members

Dr. Henry Delmar

Founder Clinique Delmar

Member of the European Board of Plastic Surgeons (EBOPRAS), specializes in Plastic, Reconstructive, and Aesthetic Surgery. President of the French Society of Aesthetic Plastic Surgery (SOFCEP) and member of IPRAS and ESPRAS.

Dr. Pierre Maldiney

Cardiologist & Anti Aging Physician

Cardiologist, morphologist, and anti-aging physician with training in nutritional and functional medicine with Professor Vincent Castronovo. President of AEM2F, the European Association of Mitronutrition and Functional Medicine.

Dr. Lin Quan

Clinical Director, UCLA

Clinical Director for preclinical research, focusing on Auto-rFib therapy research with expertise in cell culture and animal experiments. Leads preclinical investigations for neurodegenerative disease applications.

Dr. Heshan Illangkoon

Chief Innovation Officer

Biomedical engineer and translational scientist focused on turning frontier longevity and regenerative medicine research into deployable therapies. Leads NovaGen Group's innovation pipeline, bridging AI-driven discovery, clinical partners, and global research networks.

Doris Rathgerber

Owner, Body & Soul

Founder and Medical Director of Body & Soul in Shanghai. With over 20 years' experience in Traditional Chinese and Western Medicine, specializes in women's health, fertility, and pediatrics, delivering care in four languages.

Dr. Murat Bozkurt

Medical Advisor

Prof. Dr. Murat Bozkurt is a Turkish orthopedic surgeon specializing in joint surgery, arthroscopy, arthroplasty, and sports medicine. He combines extensive clinical practice in Ankara with academic, research, and international teaching activities in musculoskeletal and regenerative medicine.

Advisory Board

Global advisors across finance, partnerships, governance, and cross-border strategy.

7 members

Paul Spiegel

Strategic Advisor

International business development executive with extensive experience in Asia-Pacific markets and cross-border partnerships. Specializes in strategic planning and market expansion for biotechnology companies, with deep expertise in regulatory affairs and commercial strategy.

Neil Bush

Senior Advisor

Global business leader with 40+ years experience specializing in cross-border investments in Asia and the Middle East. Founder of the George H. W. Bush Foundation for U.S.-China Relations. Chairs Points of Light and the Bush School Advisory Board.

Anne Popkin

Strategic Advisor

Senior executive and strategic advisor with extensive experience in finance, biotechnology, and investor advocacy. Recognized for leadership roles at major asset management firms and commitment to advancing women's representation in finance. Active philanthropist supporting education, science, and ocean preservation.

Stephen Bradley

Non-Executive Director

Former British Consul-General to Hong Kong, graduated from Oxford in 1980 and studied at Fudan University. Leverages extensive diplomatic experience across Asia to advise on cross-border consultancy and strategic development. Serves on the boards of Cenovus Energy Inc., CK Asset Holdings, and Power Assets Holdings.

David Bizer

Investment Advisor

Co-founder and Managing Partner of GCW Global Customised Wealth, specializing in private equity and family office investments. Previously held senior positions at Jasper Ridge Partners, Nomura, and Lehman Brothers. Has served as an economic advisor to two U.S. Presidents. Ph.D. in Economics from Stanford University.

Rachid Bouzouba

Co-Founder, MCM Partners

Co-Founder and Chairman of MCM Partners, a Hong Kong-based merchant bank and corporate advisory firm. Accomplished finance executive with extensive leadership in global equities and derivatives, previously serving as Head of Global Equities at Nomura and Head of European Equities at Lehman Brothers.

Shirin Azad

Strategic Advisor

Shirin Azad is Strategic Advisor for Europe where she supports the company’s mission to advance investigational cellular longevity technologies. Based in London, she is an ex-headhunter, investor, and philanthropist with international experience across the UK and Germany, and she brings a strong interest in health, longevity, and patient advocacy to her work.

Questions & Answers

Frequently Asked Questions

Everything you need to know about Neo Prometheus Protocol

Can't find what you're looking for? Contact our specialist team

Treatment Process

Clinical & Scientific

Still have questions? Contact our specialist team

Contact Us

Important Medical Notice: Content on this website is educational and informational only. NovaGen Group does not provide medical advice, diagnosis, or treatment through this website. Any investigational protocol information should be discussed with qualified, licensed healthcare professionals. Availability and regulatory status vary by jurisdiction.